Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

OHSU Knight Cancer Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

OHSU Knight Cancer Institute brings 4 presentations to ASH 2026 in New Orleans, and exhibits at Booth 2523. Its research spans systemic mastocytosis, acute myeloid leukemia and lymphoma. Work covers a KIT mutant mastocytosis model, venetoclax with cladribine and a symposium on high-risk acute myeloid leukemia.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
NCI-designated comprehensive cancer center at Oregon Health & Science University in Portland, for cancer research, care and education.
Booth
Exhibiting at Booth 2523
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Decoding High-Risk AML: Applying Molecular Insights to Clinical Decision-Making
Using tests for isocitrate dehydrogenase and Flt3 mutations to guide targeted therapy choices in acute myeloid leukemia.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at OHSU Knight Cancer Institute

Tell us what you sell and we’ll find the people at OHSU Knight Cancer Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction